RATIONALE: Over 2700 e-cigarette, or vaping, product use-associated lung injury (EVALI) cases were reported to the Centers for Disease Control and Prevention (CDC) during August 2019-February 2020. Bronchoalveolar lavage (BAL) fluid samples from 51 EVALI and 99 non-EVALI cases were analyzed for toxicants including petroleum distillates. We describe a novel method to measure petroleum distillates in BAL fluid using gas chromatography-mass spectrometry (GC/MS). METHODS: n-Hexane, n-heptane, n-octane, methylcyclopentane, and cyclohexane were measured in BAL fluid specimens by headspace solid-phase microextraction/GC/MS. We created and characterized BAL fluid pools from non-EVALI individuals to determine assay accuracy, precision, linearity, limits of detection (LODs), and analytical specificity. All measurements were conducted in accordance with the rigorous method validation procedures of CDC's Division of Laboratory Sciences. RESULTS: Matrix validation experiments showed that calibration curves in BAL fluid and saline had similar slopes, with differences less than 5%. Assay precision ranged from 1.98% to 18%. In addition, the LODs for the five analytes ranged from 0.05 to 0.10 μg/L, and their linearity was confirmed with R2 values >0.99. The analysis of selected petroleum distillates in BAL fluid analysis was shown to be comparable with their analysis in blood in which the 95th percentiles are below detection. CONCLUSIONS: We developed and validated a method to quantify petroleum distillates in BAL fluid specimens using GC/MS. The assay provided precise and accurate analyses of EVALI and non-EVALI BAL fluid specimens in support of CDC's EVALI response. This method is applicable to the determination of a broad range of volatile organic compounds in BAL fluid specimens. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.
RATIONALE: Over 2700 e-cigarette, or vaping, product use-associated lung injury (EVALI) cases were reported to the Centers for Disease Control and Prevention (CDC) during August 2019-February 2020. Bronchoalveolar lavage (BAL) fluid samples from 51 EVALI and 99 non-EVALI cases were analyzed for toxicants including petroleum distillates. We describe a novel method to measure petroleum distillates in BAL fluid using gas chromatography-mass spectrometry (GC/MS). METHODS: n-Hexane, n-heptane, n-octane, methylcyclopentane, and cyclohexane were measured in BAL fluid specimens by headspace solid-phase microextraction/GC/MS. We created and characterized BAL fluid pools from non-EVALI individuals to determine assay accuracy, precision, linearity, limits of detection (LODs), and analytical specificity. All measurements were conducted in accordance with the rigorous method validation procedures of CDC's Division of Laboratory Sciences. RESULTS: Matrix validation experiments showed that calibration curves in BAL fluid and saline had similar slopes, with differences less than 5%. Assay precision ranged from 1.98% to 18%. In addition, the LODs for the five analytes ranged from 0.05 to 0.10 μg/L, and their linearity was confirmed with R2 values >0.99. The analysis of selected petroleum distillates in BAL fluid analysis was shown to be comparable with their analysis in blood in which the 95th percentiles are below detection. CONCLUSIONS: We developed and validated a method to quantify petroleum distillates in BAL fluid specimens using GC/MS. The assay provided precise and accurate analyses of EVALI and non-EVALI BAL fluid specimens in support of CDC's EVALI response. This method is applicable to the determination of a broad range of volatile organic compounds in BAL fluid specimens. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Benjamin C Blount; Robert J Kobelski; David O McElprang; David L Ashley; John C Morrow; David M Chambers; Frederick L Cardinali Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2006-02-21 Impact factor: 3.205
Authors: David M Chambers; David O McElprang; Joshua P Mauldin; Timothy M Hughes; Benjamin C Blount Journal: Anal Chem Date: 2005-05-01 Impact factor: 6.986
Authors: David M Chambers; Benjamin C Blount; David O McElprang; Michael G Waterhouse; John C Morrow Journal: Anal Chem Date: 2008-05-16 Impact factor: 6.986
Authors: Benjamin C Blount; Mateusz P Karwowski; Peter G Shields; Maria Morel-Espinosa; Liza Valentin-Blasini; Michael Gardner; Martha Braselton; Christina R Brosius; Kevin T Caron; David Chambers; Joseph Corstvet; Elizabeth Cowan; Víctor R De Jesús; Paul Espinosa; Carolina Fernandez; Cory Holder; Zsuzsanna Kuklenyik; Jennifer D Kusovschi; Cody Newman; Gregory B Reis; Jon Rees; Chris Reese; Lalith Silva; Tiffany Seyler; Min-Ae Song; Connie Sosnoff; Carleen R Spitzer; Denise Tevis; Lanqing Wang; Cliff Watson; Mark D Wewers; Baoyun Xia; Douglas T Heitkemper; Isaac Ghinai; Jennifer Layden; Peter Briss; Brian A King; Lisa J Delaney; Christopher M Jones; Grant T Baldwin; Anita Patel; Dana Meaney-Delman; Dale Rose; Vikram Krishnasamy; John R Barr; Jerry Thomas; James L Pirkle Journal: N Engl J Med Date: 2019-12-20 Impact factor: 91.245
Authors: Benjamin C Blount; Mateusz P Karwowski; Maria Morel-Espinosa; Jon Rees; Connie Sosnoff; Elizabeth Cowan; Michael Gardner; Lanqing Wang; Liza Valentin-Blasini; Lalith Silva; Víctor R De Jesús; Zsuzsanna Kuklenyik; Cliff Watson; Tiffany Seyler; Baoyun Xia; David Chambers; Peter Briss; Brian A King; Lisa Delaney; Christopher M Jones; Grant T Baldwin; John R Barr; Jerry Thomas; James L Pirkle Journal: MMWR Morb Mortal Wkly Rep Date: 2019-11-15 Impact factor: 17.586
Authors: Marta Szukalska; Krzysztof Szyfter; Ewa Florek; Juan P Rodrigo; Alessandra Rinaldo; Antti A Mäkitie; Primož Strojan; Robert P Takes; Carlos Suárez; Nabil F Saba; Boudewijn J M Braakhuis; Alfio Ferlito Journal: Cancers (Basel) Date: 2020-11-05 Impact factor: 6.639
Authors: Elizabeth A Cowan; Hang Tran; Clifford H Watson; Benjamin C Blount; Liza Valentín-Blasini Journal: Front Chem Date: 2022-04-07 Impact factor: 5.545